What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.21B, above the global median of $1.14B
- FinancialsAltman Z-Score 7.14: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
1.21BUSDvs all stocks (USD)
Trailing P/E
302.00xvs Medical Instruments & Supplies peers
Revenue (TTM)
339.59MUSDvs all stocks (USD)
Profit Margin
1.13%vs Medical Instruments & Supplies peers
Beta
1.18xvs all stocks
52-Week Change
-6.68%vs all stocks
Forward Annual Dividend Yield
0.00%vs all stocks
Market Capitalization
1.21BUSDvs all stocks (USD)
Enterprise Value
1.07BUSDvs all stocks (USD)
Trailing P/E
302.00xvs Medical Instruments & Supplies peers
Forward P/E
21.74xvs Medical Instruments & Supplies peers
PEG Ratio
-2.05xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
3.57xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.31xvs Medical Instruments & Supplies peers
Enterprise to Revenue
3.14xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
21.42xvs Medical Instruments & Supplies peers
Gross Margin
74.55%vs Medical Instruments & Supplies peers
Profit Margin
1.13%vs Medical Instruments & Supplies peers
Operating Margin
10.89%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
5.65%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
1.09%vs Medical Instruments & Supplies peers
Revenue (TTM)
339.59MUSDvs all stocks (USD)
Revenue per Share (TTM)
6.80USDUpdated Oct 28, 2026Quarterly Revenue Growth
111.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
260.20MUSDvs all stocks (USD)
EBITDA (TTM)
80.95MUSDvs all stocks (USD)
Net Income (TTM)
3.84MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
111.04%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
-3.25MUSDvs all stocks (USD)
Forward Annual Dividend Yield
0.00%vs all stocks
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
239.44MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
57.02MUSDFY2025 · Dec 31, 2025Gross Profit
182.42MUSDFY2025 · Dec 31, 2025Operating Income
-45.95MUSDvs all stocks (USD)
Pre-tax Income
-82.26MUSDFY2025 · Dec 31, 2025Income Tax Expense
-1.81MUSDFY2025 · Dec 31, 2025Net Income
-80.45MUSDFY2025 · Dec 31, 2025EBIT
-45.95MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
5.95MUSDFY2025 · Dec 31, 2025Research & Development
40.05MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
188.31MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
4.59MUSDFY2025 · Dec 31, 2025EPS (Basic)
-1.62USDFY2025 · Dec 31, 2025EPS (Diluted)
-1.62USDFY2025 · Dec 31, 2025Basic Shares Outstanding
49.57MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
49.57MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-80.45MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-55.45MUSDFY2025 · Dec 31, 2025Free Cash Flow
-61.27MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
153.15MUSDFY2025 · Dec 31, 2025Interest Paid
122.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-80.45MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
8.73MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-2.92MUSDFY2025 · Dec 31, 2025Stock-based Compensation
30.59MUSDFY2025 · Dec 31, 2025Other Non-cash Items
3.57MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
27.83MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-5.51MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-37.30MUSDFY2025 · Dec 31, 2025Capital Expenditures
-5.82MUSDFY2025 · Dec 31, 2025Purchase of Investments
-75.36MUSDFY2025 · Dec 31, 2025Sale of Investments
127.52MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
46.34MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-42.00KUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-7.98MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-8.02MUSDFY2025 · Dec 31, 2025Shares Outstanding
50.12MSharesUpdated Oct 28, 2026Float Shares
26.13MSharesUpdated Oct 28, 2026Shares Short
3.70MSharesUpdated Oct 28, 2026Short Ratio
3.76daysvs all stocks
Short % of Shares Outstanding
15.37%vs all stocks
% Held by Insiders
0.85%vs all stocks
% Held by Institutions
111.58%vs all stocks
Total Cash (MRQ)
181.49MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.62USDUpdated Oct 28, 2026Total Debt (MRQ)
35.94MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0984xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
4.67xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
7.29USDUpdated Oct 28, 2026Total Assets
451.68MUSDvs all stocks (USD)
Total Current Assets
311.55MUSDFY2025 · Dec 31, 2025Total Liabilities
107.49MUSDFY2025 · Dec 31, 2025Total Non-current Assets
140.13MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
38.99MUSDFY2025 · Dec 31, 2025Total Current Liabilities
68.50MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
153.15MUSDFY2025 · Dec 31, 2025Other Short-term Investments
34.39MUSDFY2025 · Dec 31, 2025Accounts Receivable
50.06MUSDFY2025 · Dec 31, 2025Inventory
55.50MUSDFY2025 · Dec 31, 2025Accounts Payable
11.57MUSDFY2025 · Dec 31, 2025Short-term Debt
5.87MUSDFY2025 · Dec 31, 2025Other Current Liabilities
24.77MUSDFY2025 · Dec 31, 2025Long-term Debt
32.48MUSDFY2025 · Dec 31, 2025Common Stock (Book)
498.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-148.02MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
344.18MUSDvs all stocks (USD)
Treasury Stock
6.46MUSDFY2025 · Dec 31, 202552-Week Low
15.59USDUpdated Oct 28, 202652-Week High
35.87USDUpdated Oct 28, 202652-Week Change
-6.68%vs all stocks
Beta
1.18xvs all stocks
50-Day MA
22.38USDUpdated Oct 28, 2026200-Day MA
23.56USDUpdated Oct 28, 2026Avg 10-Day Volume
556.18KSharesUpdated Oct 28, 2026Avg 30-Day Volume
864.34KSharesUpdated Oct 28, 2026Diluted EPS (TTM)
0.0800USDUpdated Oct 28, 2026Other Income / Expense
-40.91MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 3,839,000Operating Cash Flow (USD, TTM): -3,252,000
High gross margins eroded by operating costsNotable
Gross Margin: 0.75Profit Margin: 0.01
Financial Health
Altman Z-Score 7.14: safe zoneNotable
Altman Z-Score: 7.14
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.21B, above the global median of $1.14BNotable
Market cap (USD): 1,211,478,653Global Median: 1,137,180,293.291
Companies that share the same coordination system — how they create, deliver, or capture value.
Sansure Biotech Inc.
Tier 1ProductionThroughput-Bound ConversionRule
Jiangsu Haili Wind Power Equipment Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
M.P. Evans Group PLC
Tier 1ProductionThroughput-Bound ConversionRiskRule
Pearl Global Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
OMH Science Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Cascades Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Loma Negra C.I.A. Lomas de Zamora S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Chengdu Haoneng Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Myers Industries Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ambiq Micro, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule